2018 ESC/EACTS Guidelines on myocardial revascularization
M Sousa-Uva, FJ Neumann, A Ahlsson… - European Journal of …, 2019 - academic.oup.com
These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …
Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus
The continuing increase in the prevalence of diabetes mellitus in the general population is
predicted to result in a higher incidence of cardiovascular disease. Although the …
predicted to result in a higher incidence of cardiovascular disease. Although the …
2018 ESC/EACTS Guidelines on myocardial revascularization
FJ Neumann, M Sousa-Uva, A Ahlsson… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …
websites. The National Societies of the ESC are encouraged to endorse, translate, and …
Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis
L Edgar, N Akbar, AT Braithwaite, T Krausgruber… - Circulation, 2021 - Am Heart Assoc
Background: Cardiovascular risk in diabetes remains elevated despite glucose-lowering
therapies. We hypothesized that hyperglycemia induces trained immunity in macrophages …
therapies. We hypothesized that hyperglycemia induces trained immunity in macrophages …
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association
SD De Ferranti, IH De Boer, V Fonseca, CS Fox… - Circulation, 2014 - Am Heart Assoc
(CVD) in individuals with type 1 diabetes mellitus (T1DM), the pathophysiology underlying
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …
Diabetes, heart failure, and renal dysfunction: the vicious circles
E Braunwald - Progress in cardiovascular diseases, 2019 - Elsevier
The prevalence of Type 2 diabetes mellitus (T2DM) has reached pandemic proportions.
T2DM frequently causes macrovascular and/or microvascular pathologic changes and …
T2DM frequently causes macrovascular and/or microvascular pathologic changes and …
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
ContextTraditionally, stent thrombosis has been regarded as a complication of percutaneous
coronary interventions during the first 30 postprocedural days. However, delayed …
coronary interventions during the first 30 postprocedural days. However, delayed …
[HTML][HTML] Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor …
Objective We evaluated sodium-glucose co-transporter2 (SGLT2) expression and the effect
of SGLT2 inhibitor (SGLT2i) therapies on carotid plaques of asymptomatic diabetic and non …
of SGLT2 inhibitor (SGLT2i) therapies on carotid plaques of asymptomatic diabetic and non …
Pathogenesis of lipid disorders in insulin resistance: a brief review
P Bjornstad, RH Eckel - Current diabetes reports, 2018 - Springer
Purpose of review Insulin resistance (IR) is recognized to play an important role in the
pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR …
pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR …
Monocytes, macrophages, and metabolic disease in atherosclerosis
Atherosclerotic cardiovascular disease (CVD) is a lipid-driven chronic inflammatory disease,
in which macrophages are responsible for taking up these lipids and driving disease …
in which macrophages are responsible for taking up these lipids and driving disease …